Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-18

Clinical Trial Update: Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK [NA]

View source ↗

Summary

Completed trial comparing 1-hour versus 2-hour illumination in indoor daylight photodynamic therapy for scalp actinic keratosis to evaluate whether shorter expo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: San Salvatore Hospital of L'Aquila | Conditions: Actinic Keratosis (AK) | NA | Status: COMPLETED